Pharmacological Prophylaxis of Venous Thromboembolism in Terminally Ill Patients: A Need or Futility?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12932 |
Resumo: | The aim of this case is to clarify the need to maintain the terminally ill oncological patients who have had a thrombotic event in the course of their underlying disease under antithrombotic therapy. This case addresses a 63-year-old man with stage IV gastric antrum adenocarcinoma, completely bed-ridden and anticoagulated with subcutaneous enoxaparin for more than a year, following deep venous thrombosis of the left lower limb. After reviewing the literature, it was found that, for end-of-life patients, anticoagulation seems to have little benefit as the main objective is not the extension of life itself, but rather the preservation of the best quality of life through practices that are well established in the relief of suffering. |
id |
RCAP_1fbd8b781cf8545d79d01399a0c5a609 |
---|---|
oai_identifier_str |
oai:ojs.www.actamedicaportuguesa.com:article/12932 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Pharmacological Prophylaxis of Venous Thromboembolism in Terminally Ill Patients: A Need or Futility?Profilaxia Farmacológica do Tromboembolismo Venoso em Doentes Terminais: Uma Necessidade ou um Desperdício?Anticoagulants/therapeutic useEnoxaparinFibrinolytic AgentsPalliative CareVenous Thromboembolism/prevention & controlThe aim of this case is to clarify the need to maintain the terminally ill oncological patients who have had a thrombotic event in the course of their underlying disease under antithrombotic therapy. This case addresses a 63-year-old man with stage IV gastric antrum adenocarcinoma, completely bed-ridden and anticoagulated with subcutaneous enoxaparin for more than a year, following deep venous thrombosis of the left lower limb. After reviewing the literature, it was found that, for end-of-life patients, anticoagulation seems to have little benefit as the main objective is not the extension of life itself, but rather the preservation of the best quality of life through practices that are well established in the relief of suffering.O presente caso pretende clarificar qual a verdadeira necessidade de manter sob terapêutica anti-trombótica os doentes oncológicos terminais que tiveram um evento trombótico no decorrer da evolução da sua doença de base. O caso em questão aborda um doente de 63 anos com uma neoplasia do antro gástrico em estadio IV, totalmente acamado, hipocoagulado com enoxaparina subcutânea há mais de um ano, no seguimento de uma trombose venosa profunda no membro inferior esquerdo. Após revisão da literatura, constatou-se que em doentes em fim de vida, a anticoagulação parece ter pouco benefício, visto que o principal objetivo não é o prolongamento da vida, mas sim a preservação da melhor qualidade de vida possível através de práticas cuja evidência no alívio do sofrimento está bem documentada.Ordem dos Médicos2022-02-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/pdfapplication/pdfapplication/vnd.openxmlformats-officedocument.wordprocessingml.documentapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12932oai:ojs.www.actamedicaportuguesa.com:article/12932Acta Médica Portuguesa; Vol. 35 No. 2 (2022): February; 147-149Acta Médica Portuguesa; Vol. 35 N.º 2 (2022): Fevereiro; 147-1491646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12932https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12932/6258https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12932/11907https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12932/11948https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12932/12412https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12932/12900Direitos de Autor (c) 2021 Acta Médica Portuguesainfo:eu-repo/semantics/openAccessSerranito, LauraReis-Pina, Paulo2022-12-20T11:06:44Zoai:ojs.www.actamedicaportuguesa.com:article/12932Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:20:15.220199Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Pharmacological Prophylaxis of Venous Thromboembolism in Terminally Ill Patients: A Need or Futility? Profilaxia Farmacológica do Tromboembolismo Venoso em Doentes Terminais: Uma Necessidade ou um Desperdício? |
title |
Pharmacological Prophylaxis of Venous Thromboembolism in Terminally Ill Patients: A Need or Futility? |
spellingShingle |
Pharmacological Prophylaxis of Venous Thromboembolism in Terminally Ill Patients: A Need or Futility? Serranito, Laura Anticoagulants/therapeutic use Enoxaparin Fibrinolytic Agents Palliative Care Venous Thromboembolism/prevention & control |
title_short |
Pharmacological Prophylaxis of Venous Thromboembolism in Terminally Ill Patients: A Need or Futility? |
title_full |
Pharmacological Prophylaxis of Venous Thromboembolism in Terminally Ill Patients: A Need or Futility? |
title_fullStr |
Pharmacological Prophylaxis of Venous Thromboembolism in Terminally Ill Patients: A Need or Futility? |
title_full_unstemmed |
Pharmacological Prophylaxis of Venous Thromboembolism in Terminally Ill Patients: A Need or Futility? |
title_sort |
Pharmacological Prophylaxis of Venous Thromboembolism in Terminally Ill Patients: A Need or Futility? |
author |
Serranito, Laura |
author_facet |
Serranito, Laura Reis-Pina, Paulo |
author_role |
author |
author2 |
Reis-Pina, Paulo |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Serranito, Laura Reis-Pina, Paulo |
dc.subject.por.fl_str_mv |
Anticoagulants/therapeutic use Enoxaparin Fibrinolytic Agents Palliative Care Venous Thromboembolism/prevention & control |
topic |
Anticoagulants/therapeutic use Enoxaparin Fibrinolytic Agents Palliative Care Venous Thromboembolism/prevention & control |
description |
The aim of this case is to clarify the need to maintain the terminally ill oncological patients who have had a thrombotic event in the course of their underlying disease under antithrombotic therapy. This case addresses a 63-year-old man with stage IV gastric antrum adenocarcinoma, completely bed-ridden and anticoagulated with subcutaneous enoxaparin for more than a year, following deep venous thrombosis of the left lower limb. After reviewing the literature, it was found that, for end-of-life patients, anticoagulation seems to have little benefit as the main objective is not the extension of life itself, but rather the preservation of the best quality of life through practices that are well established in the relief of suffering. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-02-01 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12932 oai:ojs.www.actamedicaportuguesa.com:article/12932 |
url |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12932 |
identifier_str_mv |
oai:ojs.www.actamedicaportuguesa.com:article/12932 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12932 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12932/6258 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12932/11907 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12932/11948 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12932/12412 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12932/12900 |
dc.rights.driver.fl_str_mv |
Direitos de Autor (c) 2021 Acta Médica Portuguesa info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Direitos de Autor (c) 2021 Acta Médica Portuguesa |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf application/vnd.openxmlformats-officedocument.wordprocessingml.document application/pdf |
dc.publisher.none.fl_str_mv |
Ordem dos Médicos |
publisher.none.fl_str_mv |
Ordem dos Médicos |
dc.source.none.fl_str_mv |
Acta Médica Portuguesa; Vol. 35 No. 2 (2022): February; 147-149 Acta Médica Portuguesa; Vol. 35 N.º 2 (2022): Fevereiro; 147-149 1646-0758 0870-399X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130651090223104 |